DNTH103
DNTH103-MG-201
Phase 2 small_molecule active
Quick answer
DNTH103 for Myasthenia Gravis, Generalized is a Phase 2 program (small_molecule) at Dianthus Therapeutics, Inc. /DE/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dianthus Therapeutics, Inc. /DE/
- Indication
- Myasthenia Gravis, Generalized
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active